clinical trial · NCT01072539
Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Pfizer·—·completed·n = 3,172
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal InfectionsCommunity-Acquired Bacterial Pneumoniatigecycline
brief summary
The primary objective of this study is to identify any changes on the safety profile of adverse events and serious adverse events. And the secondary objective is to evaluate clinical response in the clinically evaluable population at test-of cure (TOC) or at the end of treatment (EOT) assessment, and microbiologic response at the subject level, if available.
started
May 1, 2010
primary completion
Apr 1, 2015
completion
Apr 1, 2015
last updated
Dec 29, 2023
detailed description
Prior to the conduct of this study, the investigator will explain the study objective, etc to prospective subjects on the basis of "explanatory material." The informed consent will be obtained in written form by each subject voluntarily.
official title
A Post-marketing Surveillance (Pms) Study Of Safety And Effectiveness In Patients With Tigecycline Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol